Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
How about posting the news?
It doesn't show up on my Schwab news.
Manny
ACFN,
GridSense, an Acorn Energy Company, Announces New Substation Monitoring Application at Two Utilities
GridSense, an Acorn Energy (NASDAQ: ACFN) company that develops and markets advanced monitoring solutions for the electric power industry, has announced that two major utilities will use its LineIQ™ overhead line monitoring solution to cost-effectively collect intelligence from previously unmonitored substations.
(Logo: http://photos.prnewswire.com/prnh/20120504/NY01341LOGO)(Logo: http://photos.prnewswire.com/prnh/20120426/NY96114LOGO)
Even in this era of the emerging smart grid, a significant percentage of substations lack intelligence of any kind. Traditionally, retrofitting substations to provide remote intelligence required a time and cost commitment to full metering. In many instances, even spot monitoring inside the substation is particularly expensive due to internal and regulatory requirements. Considering that utilities might have up to 1000 lines feeding into their substations, the cost and time for retrofit can quickly grow prohibitive.
To gain intelligence at unmonitored substations in a cost effective manner, two US utilities will deploy GridSense LineIQ™ to monitor 15kV and 69kV feeder lines as they come into—but before they reach—the substation. "It was only through working closely with the utilities that we realized how serious an issues this was," says Brandy Henson, GridSense Sales Manager. "The two utilities helped us understand how we could extend the product to offer a unique response to a surprisingly common problem."
The utilities chose LineIQ™ because it allows them to leverage their substations' existing communications networks, whether cellular, WiFi, or wireless networks. The technology is compatible with multiple options, in this instance one utility is using the Silver Spring radio and the other the Sensus radio. In addition, LineIQ's solar power with battery backup lets both utilities avoid the time and cost of tapping into the substation power supply.
Using LineIQ™, these organizations are bypassing the high cost of metering at the substation, while gaining smart grid intelligence that can help prevent outages and guarantee the quality and reliability of supply. The programmable units will monitor faults, current, voltage, and record and log ambient and conductor temperature.
"LineIQ's self-powered mechanism, expansive communications options and advanced sensing capabilities are providing new ways to identify issues before they become outages," Says Henson. "In unmonitored substations, the industry needs the smart grid benefit of practicing preventive maintenance instead of reactive repair. LineIQ™ now provides that in a way that's more cost-effective than previously thought possible."
About GridSense Inc. GridSense is a smart grid technology company dedicated to providing innovative, practical and cost effective monitoring solutions to the electric power industry. Utilizing in-depth industry knowledge and understanding of utility requirements, we provide technology and services that help the industry address the limitations of old and aging infrastructure. We apply experience and technical know-how with new insight and ideas to create intelligent, reliable and leading edge technologies that add value to our customers and shape the future of the modern electrical power system.
About Acorn Energy, Inc. Acorn Energy, Inc. is a holding company focused on making energy better by providing digital solutions for energy infrastructure asset management. The four businesses in which we have controlling interests, improve the world's energy infrastructure by making it: more secure - providing security solutions for underwater energy infrastructure (DSIT); more reliable - providing condition-based monitoring to critical assets on the electric grid (GridSense, OmniMetrix) and more productive and efficient - increasing oil and gas production while lowering costs through use of permanent ultra-high sensitive seismic tools that allow for a more precise picture of reservoirs (US Seismic). For more information visit: http://www.acornenergy.com.
Safe Harbor StatementThis press release includes forward-looking statements, which are subject to risks and uncertainties. There is no assurance that Acorn Energy, Inc. or its operating companies will continue to grow their respective businesses, or that any of them will meet the expectations or execute the initiatives described or referred to above. A complete discussion of the risks and uncertainties which may affect Acorn Energy's business generally and the businesses of its subsidiaries is included in "Risk Factors" in its most recent Annual Report on Form 10-K and its 2012 First Quarter 10-Q as filed by Acorn Energy with the Securities and Exchange Commission.
Contact: Leonce GaiterTel: 916.372.4945Email: l.gaiter@gridsense.com
SOURCE Acorn Energy, Inc.
ACFN,
GridSense, an Acorn Energy Company, Announces New Substation Monitoring Application at Two Utilities
GridSense, an Acorn Energy (NASDAQ: ACFN) company that develops and markets advanced monitoring solutions for the electric power industry, has announced that two major utilities will use its LineIQ™ overhead line monitoring solution to cost-effectively collect intelligence from previously unmonitored substations.
(Logo: http://photos.prnewswire.com/prnh/20120504/NY01341LOGO)(Logo: http://photos.prnewswire.com/prnh/20120426/NY96114LOGO)
Even in this era of the emerging smart grid, a significant percentage of substations lack intelligence of any kind. Traditionally, retrofitting substations to provide remote intelligence required a time and cost commitment to full metering. In many instances, even spot monitoring inside the substation is particularly expensive due to internal and regulatory requirements. Considering that utilities might have up to 1000 lines feeding into their substations, the cost and time for retrofit can quickly grow prohibitive.
To gain intelligence at unmonitored substations in a cost effective manner, two US utilities will deploy GridSense LineIQ™ to monitor 15kV and 69kV feeder lines as they come into—but before they reach—the substation. "It was only through working closely with the utilities that we realized how serious an issues this was," says Brandy Henson, GridSense Sales Manager. "The two utilities helped us understand how we could extend the product to offer a unique response to a surprisingly common problem."
The utilities chose LineIQ™ because it allows them to leverage their substations' existing communications networks, whether cellular, WiFi, or wireless networks. The technology is compatible with multiple options, in this instance one utility is using the Silver Spring radio and the other the Sensus radio. In addition, LineIQ's solar power with battery backup lets both utilities avoid the time and cost of tapping into the substation power supply.
Using LineIQ™, these organizations are bypassing the high cost of metering at the substation, while gaining smart grid intelligence that can help prevent outages and guarantee the quality and reliability of supply. The programmable units will monitor faults, current, voltage, and record and log ambient and conductor temperature.
"LineIQ's self-powered mechanism, expansive communications options and advanced sensing capabilities are providing new ways to identify issues before they become outages," Says Henson. "In unmonitored substations, the industry needs the smart grid benefit of practicing preventive maintenance instead of reactive repair. LineIQ™ now provides that in a way that's more cost-effective than previously thought possible."
About GridSense Inc. GridSense is a smart grid technology company dedicated to providing innovative, practical and cost effective monitoring solutions to the electric power industry. Utilizing in-depth industry knowledge and understanding of utility requirements, we provide technology and services that help the industry address the limitations of old and aging infrastructure. We apply experience and technical know-how with new insight and ideas to create intelligent, reliable and leading edge technologies that add value to our customers and shape the future of the modern electrical power system.
About Acorn Energy, Inc. Acorn Energy, Inc. is a holding company focused on making energy better by providing digital solutions for energy infrastructure asset management. The four businesses in which we have controlling interests, improve the world's energy infrastructure by making it: more secure - providing security solutions for underwater energy infrastructure (DSIT); more reliable - providing condition-based monitoring to critical assets on the electric grid (GridSense, OmniMetrix) and more productive and efficient - increasing oil and gas production while lowering costs through use of permanent ultra-high sensitive seismic tools that allow for a more precise picture of reservoirs (US Seismic). For more information visit: http://www.acornenergy.com.
Safe Harbor StatementThis press release includes forward-looking statements, which are subject to risks and uncertainties. There is no assurance that Acorn Energy, Inc. or its operating companies will continue to grow their respective businesses, or that any of them will meet the expectations or execute the initiatives described or referred to above. A complete discussion of the risks and uncertainties which may affect Acorn Energy's business generally and the businesses of its subsidiaries is included in "Risk Factors" in its most recent Annual Report on Form 10-K and its 2012 First Quarter 10-Q as filed by Acorn Energy with the Securities and Exchange Commission.
Contact: Leonce GaiterTel: 916.372.4945Email: l.gaiter@gridsense.com
SOURCE Acorn Energy, Inc.
NAVB,
Now at 3.39,up 2.73% for day.Hopefully some big ARNA winnings go into this play..
Help Wanted
I like this one: Quality Assurance Compliance Specialist – Regulatory
http://www.navidea.com/about-us/careers.html
Manny
MMRGlobal Reports Growth in Physician Usage of MMRPro and Increase in Web Traffic to Personal Health Record Sites
MMRGlobal, Inc. (OTCBB: MMRF) ("MMR") today announced that usage of the Company's MMRPro document management and imaging systems processed nearly 3 million pages of medical records from an estimated 100,000 patients including more than 500,000 EOB forms for use with medical billing and collection services. MMRPro also makes medical records available to patients using the system's integrated patient portal, MMRPatientView, and the joint MMR-Interbit Data solution certified for meaningful use with MEDITECH EMR systems. Over the past five months, the Company continued to see usage grow at more than 12% over last year.
According to Bob Lorsch, MMRGlobal Chairman and CEO, "Opportunities with MMRPro seem to be opening up. Originally designed for small physician practices, we find growth coming from other areas such as surgery centers, compliance departments and in support of billing and collections. The increase in document imaging should continue to track to rising implementation of Electronic Medical Records systems which require digitizing paper-based patient charts for use with EMR and EHR systems."
Separately, the Company also reported that it sees measurable increases in video tours of its MyMedicalrecords.com Personal Health Record, MyEsafeDepositbox.com online storage system and other MMR websites all of which can be viewed at www.mmrtheater.com. Continued Lorsch, "Increasing numbers of consumers are beginning to see the importance and cost saving benefits of having a PHR (http://coosaw.wordpress.com/2012/03/15/medical/). Based on comments from users, we believe that we offer the most user-friendly interface to all of a family's healthcare providers, including veterinarians for the family's pets."
The Company has also been running a Facebook advertising campaign that has already delivered 18 million impressions since the first of June. The campaign uses targeted messages which drive people to both disease-specific and family wellness pages such as https://www.mymedicalrecords.com/diabetes and https://www.mymedicalrecords.com/family. Based on the Facebook campaign and an article about the Company in yesterday's edition of The Daily Beast (http://www.thedailybeast.com/articles/2012/06/14/inside-real-housewives-star-taylor-armstrong-s-lawsuit-settlement.html), the Company is seeing thousands of visitors to its websites.
ACFN,
The manipulation of these stocks is just incredible.
Yesterday it hit a low of 7.74.Today it is up 4.66% to 8.38.
ACFN is on the preliminary list to be added to the Russel Global and Russel 3000.
Manny
PSGY,
Congratulations to KIK and other holders.
Being bought for .89 cash by Thermo Fisher Scientific Inc.
Thermo Fisher Scientific to Acquire Princeton Security
Princeton Security Technologies, Inc. (OTCBB: PSGY) (referred to herein as "Princeton"), a developer and manufacturer of detector products, including x-ray and gamma-ray detectors, spectroscopy systems, and radioisotope identifier products, today announced that it has entered into a definitive merger agreement with Thermo Fisher Scientific Inc. ("Thermo Fisher"), under which Thermo Fisher will acquire all the outstanding shares of Princeton for $0.89 per share in cash, in a transaction valued at approximately $13 million.
Under the terms of the merger agreement, a wholly owned subsidiary of Thermo Fisher will merge into Princeton, with Princeton as the surviving corporation, and each outstanding share of common stock of Princeton (other than dissenting shares) will be converted into the right to receive $0.89 per share, in cash. This price represents a premium of 78% over the closing share price of Princeton's common stock on June 12, 2012. The Board of Directors of Princeton has unanimously approved the merger. In addition, holders of Princeton common stock constituting approximately 71.2% of Princeton's outstanding shares have executed and delivered to Princeton written consents adopting the merger agreement, as a result of which the required stockholder approval of the merger has been obtained and no further action by Princeton stockholders is required in connection with the transaction.
The closing of the merger is subject to the satisfaction or waiver of customary closing conditions, including the absence of any legal restraint, injunction or other action that would prohibit the merger, and the absence of any event that constitutes a material adverse effect (as defined in the merger agreement) on Princeton. The closing is also subject to the condition that the time period for the holders of Princeton common stock to exercise dissenters' rights under Nevada law shall have expired and no more than 10% of the issued and outstanding shares of Princeton common stock shall be dissenting shares. The transaction is expected to close during July 2012.
"We believe the merger is an excellent opportunity for the Princeton customers, employees and stockholders," said Juhani Taskinen, Princeton President and Chief Executive Officer. "It will provide the Princeton stockholders with the opportunity to realize a substantial premium to Princeton's current share price. In addition, the combination of Thermo Fisher's global reach and leadership in radiation measurement and monitoring with Princeton's innovative detector technology represents a coupling of complementary strengths that will benefit our customers and employees."
CoView Capital, Inc., a New York-based middle-market investment banking firm, was retained by the Princeton board of directors to render a fairness opinion with regard to the transaction.
Please see the "Additional Information" section below for further information regarding the merger that will be made available to all stockholders.
About Princeton Security Technologies, Inc.
Princeton Security, a Nevada corporation founded in 2005, develops, manufactures and markets a line of detector products, including x-ray and gamma-ray detectors, spectroscopy systems, and radioisotope identifier products. Our products are used for industrial, commercial and security applications ranging from the homeland security need to detect concealed radioactive material to silicon wafer fabrication companies that use our products and components to analyze silicon wafers for defects. We manufacture individual detection units and component parts for larger units manufactured and sold by third parties.
PSGY,
Congratulations to KIK and other holders.
Being bought for .89 cash by Thermo Fisher Scientific Inc.
Thermo Fisher Scientific to Acquire Princeton Security
Princeton Security Technologies, Inc. (OTCBB: PSGY) (referred to herein as "Princeton"), a developer and manufacturer of detector products, including x-ray and gamma-ray detectors, spectroscopy systems, and radioisotope identifier products, today announced that it has entered into a definitive merger agreement with Thermo Fisher Scientific Inc. ("Thermo Fisher"), under which Thermo Fisher will acquire all the outstanding shares of Princeton for $0.89 per share in cash, in a transaction valued at approximately $13 million.
Under the terms of the merger agreement, a wholly owned subsidiary of Thermo Fisher will merge into Princeton, with Princeton as the surviving corporation, and each outstanding share of common stock of Princeton (other than dissenting shares) will be converted into the right to receive $0.89 per share, in cash. This price represents a premium of 78% over the closing share price of Princeton's common stock on June 12, 2012. The Board of Directors of Princeton has unanimously approved the merger. In addition, holders of Princeton common stock constituting approximately 71.2% of Princeton's outstanding shares have executed and delivered to Princeton written consents adopting the merger agreement, as a result of which the required stockholder approval of the merger has been obtained and no further action by Princeton stockholders is required in connection with the transaction.
The closing of the merger is subject to the satisfaction or waiver of customary closing conditions, including the absence of any legal restraint, injunction or other action that would prohibit the merger, and the absence of any event that constitutes a material adverse effect (as defined in the merger agreement) on Princeton. The closing is also subject to the condition that the time period for the holders of Princeton common stock to exercise dissenters' rights under Nevada law shall have expired and no more than 10% of the issued and outstanding shares of Princeton common stock shall be dissenting shares. The transaction is expected to close during July 2012.
"We believe the merger is an excellent opportunity for the Princeton customers, employees and stockholders," said Juhani Taskinen, Princeton President and Chief Executive Officer. "It will provide the Princeton stockholders with the opportunity to realize a substantial premium to Princeton's current share price. In addition, the combination of Thermo Fisher's global reach and leadership in radiation measurement and monitoring with Princeton's innovative detector technology represents a coupling of complementary strengths that will benefit our customers and employees."
CoView Capital, Inc., a New York-based middle-market investment banking firm, was retained by the Princeton board of directors to render a fairness opinion with regard to the transaction.
Please see the "Additional Information" section below for further information regarding the merger that will be made available to all stockholders.
About Princeton Security Technologies, Inc.
Princeton Security, a Nevada corporation founded in 2005, develops, manufactures and markets a line of detector products, including x-ray and gamma-ray detectors, spectroscopy systems, and radioisotope identifier products. Our products are used for industrial, commercial and security applications ranging from the homeland security need to detect concealed radioactive material to silicon wafer fabrication companies that use our products and components to analyze silicon wafers for defects. We manufacture individual detection units and component parts for larger units manufactured and sold by third parties.
ACFN,
The hedge funds and other Short Sellers have plenty of money to manipulate stocks.
It is definitely better to buy on a trend change.
Manny
ACFN,
CEO buys 10,000 shares at average 8.044.Stock currently 7.99.
http://www.secform4.com/insider-trading/880984.htm
Manny
ACFN,
CEO buys 10,000 shares at average 8.044,Stock currently 7.99.
http://www.secform4.com/insider-trading/880984.htm
Manny
Officers sold on 6/6/12.
http://www.secform4.com/insider-trading/1344413.htm
All 4 conveniently set up their selling plan on the same date,March 29,2012.
Shares vested on the 6/5/12,and they sold on 6/6/12.
http://www.secform4.com/filings/1344413/000120919112033064.htm
( 1 )Represents shares issued as restricted stock units (an "RSU") under the Issuer's 2005 Equity Incentive Plan (the "Plan") that vested in full on June 5, 2012. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 29, 2012.
This poor Director who bought 100,000 shares for .54 on 4/11/12,obviously didn't know what was coming.
http://www.secform4.com/filings/1344413/000120919112022811.htm
Manny
CIGX,
S-3 filing. for up to 10.8 million shares.
http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=8318291
Manny
CIGX,
S-3 filing. for up to 10.8 million shares.
http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=8318291
Manny
SARA is on the list of possible addition to the Russell Global and Russell Microcap.
http://www.russell.com/indexes/tools-resources/reconstitution/reconstitution-changes.asp
Manny
Russell Index additons
It looks like Mart Resources (MMT.V,MAUXF) is on the preliminary additions for the Russell Global, Russell 3000® and Russell Microcap® Indexes.
http://www.russell.com/indexes/tools-resources/reconstitution/reconstitution-changes.asp
Manny
Russell Index additons
It looks like Mart Resources (MMT.V,MAUXF) and ACFN is on the preliminary additions for the
Russell Global, Russell 3000® and Russell Microcap® Indexes.
http://www.russell.com/indexes/tools-resources/reconstitution/reconstitution-changes.asp
Manny
ACFN,
Up 4.8% to 8.74.
It was already 13.20 high.
I found this newsletter report on ACFN from Vista Partners with a target of 14.
Acorn Energy, Inc. (NasdaqGM: ACFN)
Current Price: $8.34
Target Price: $14.00
Acorn Energy, Inc.’s (the “Company” or “ACFN”) share price is up 79% since we initiated coverage in September 2011 (not including dividend payments). John and I visited US Seismic Systems, Inc. (USSI), a subsidiary of ACFN on May 9th at their headquarters in Woodland Hills for their analyst day which was well attended. We came away impressed and excited regarding both the revenue potential for USSI and also the enormous size of the markets they intend to serve. The Company remains steadfast by its statement made on earnings calls that USSI will announce commercial orders by the end of the second quarter, June 30, 2012.
Jim Andersen, Founder and President of USSI, testified on May 10, 2012 at the United States House of Representatives' Science, Space, and Technology Subcommittee on Energy & Environment hearing titled "Supporting American Jobs and the Economy Through Expanded Energy Production: Challenges and Opportunities of Unconventional Resources Technology." The purpose of this hearing was to examine both the challenges and opportunities associated with expanding development and use of unconventional oil and gas production technologies. Mr. Andersen gave an overview of USSI Fiber Optic Sensing Technology and its potential impact to both enhance oil and gas recovery and improve environmental monitoring to better ensure safe and responsible production.
OmniMetrix, LLC, an Acorn Energy company, made its 5th appearance at the International CTIA Wireless in New Orleans, LA., May 8-10, 2012. OmniMetrix introduced their new 4G enabled product lines for generator monitoring control. By developing 4G enabled devices now, customers will be safely transitioned to the latest technology long before legacy systems are phased out. The industry unique pricing structures they have developed for their G8500 products that monitor emergency generator systems are turning residential & industrial consumers into lasting customers.
On May 10, 2012, Acorn announced the results for the first quarter ended March 31, 2012. John Moore, CEO of Acorn Energy, stated, "The first quarter of 2012 set the stage for another exciting year for Acorn Energy. We continue to focus on applying innovative technologies to make the huge world-wide energy infrastructure cleaner, safer, cheaper and more reliable. At the same time alternative energy has attracted great attention and capital. More recently, for a number of very logical and practical reasons, the alternative energy noise has quieted, and the Acorn thesis of getting more out of what we have'is gaining traction. The recent economic viability of huge new oil and gas reserves through horizontal drilling and fracking technologies underscores a simple fact: the U.S. use of fossil fuels cannot be meaningfully reduced by alternative energies within the next two or three decades.”
Acorn Energy attended the Las Vegas Money Show on May 14-17 where CEO, John A. Moore gave a presentation. His presentation, "The Surprising Transformation of Our Energy Structure, Which Will Drive the Next Era of Prosperity" offered his insight into Digital Energy and comment on notable contrasts with both wind and solar energy. Please visit www.acornenergy.com to view additional commentary.
DSIT exhibited the company's underwater security systems and other sonar and acoustic solutions at the Undersea Defence Technologies (UDT) Conference and Exhibition in Alicante, Spain (May 29 – 31, 2012). The company viewed UDT as an important venue for reaching decision makers in fields related to undersea defense and security; and has been an exhibitor at this event for the last several years.
John Moore presented at the Barrington Research Industrial & Business Services Conference on Tuesday, May 15 in Chicago, IL. Acorn Energy presented at the 3rd Annual Benchmark Company, LLC One-on-One Investor Conference Thursday, May 31, 2012 in Milwaukee, WI. The Company attended the SeeThruEquity First Annual Small Cap Investor Conference on Tuesday, June 5, 2012 at The Cornell Club in New York City. The Company is presenting at the 10th Annual Ardour Capital Energy Technology Conference. The conference is in New York City from June 7-8, 2012.
GridSense, an Acorn Energy, Inc. (ACFN) company, previewed Grid InSite™, its new software platform, at the Municipal Smart Grid Summit in San Diego, June 4-6. Grid InSite™ will provide utilities with a powerful grid optimization system that seamlessly integrates GridSense sensors and intelligent nodes to enable monitoring and control of transmission and distribution assets.
Acorn offers a quarterly dividend of $0.035 per share. The dividend helps to make Acorn a very compelling investment opportunity considering the Company has successfully sold two portfolio companies validating its model and is paying a quarterly dividend to shareholders which mitigates some of the risk. The Company’s portfolio consists of 'capital–light' businesses with high or potentially high margins and first mover advantages in what could be billion dollar markets.
For additional information on Acorn Energy, Inc. please download our free update of coverage report dated February 22, 2012; the report is available on our website: www.vistapglobal.com.
ACFN,
Up 4.8% to 8.74.
It was already 13.20 high.
I found this newsletter report on ACFN from Vista Partners with a target of 14.
Acorn Energy, Inc. (NasdaqGM: ACFN)
Current Price: $8.34
Target Price: $14.00
Acorn Energy, Inc.’s (the “Company” or “ACFN”) share price is up 79% since we initiated coverage in September 2011 (not including dividend payments). John and I visited US Seismic Systems, Inc. (USSI), a subsidiary of ACFN on May 9th at their headquarters in Woodland Hills for their analyst day which was well attended. We came away impressed and excited regarding both the revenue potential for USSI and also the enormous size of the markets they intend to serve. The Company remains steadfast by its statement made on earnings calls that USSI will announce commercial orders by the end of the second quarter, June 30, 2012.
Jim Andersen, Founder and President of USSI, testified on May 10, 2012 at the United States House of Representatives' Science, Space, and Technology Subcommittee on Energy & Environment hearing titled "Supporting American Jobs and the Economy Through Expanded Energy Production: Challenges and Opportunities of Unconventional Resources Technology." The purpose of this hearing was to examine both the challenges and opportunities associated with expanding development and use of unconventional oil and gas production technologies. Mr. Andersen gave an overview of USSI Fiber Optic Sensing Technology and its potential impact to both enhance oil and gas recovery and improve environmental monitoring to better ensure safe and responsible production.
OmniMetrix, LLC, an Acorn Energy company, made its 5th appearance at the International CTIA Wireless in New Orleans, LA., May 8-10, 2012. OmniMetrix introduced their new 4G enabled product lines for generator monitoring control. By developing 4G enabled devices now, customers will be safely transitioned to the latest technology long before legacy systems are phased out. The industry unique pricing structures they have developed for their G8500 products that monitor emergency generator systems are turning residential & industrial consumers into lasting customers.
On May 10, 2012, Acorn announced the results for the first quarter ended March 31, 2012. John Moore, CEO of Acorn Energy, stated, "The first quarter of 2012 set the stage for another exciting year for Acorn Energy. We continue to focus on applying innovative technologies to make the huge world-wide energy infrastructure cleaner, safer, cheaper and more reliable. At the same time alternative energy has attracted great attention and capital. More recently, for a number of very logical and practical reasons, the alternative energy noise has quieted, and the Acorn thesis of getting more out of what we have'is gaining traction. The recent economic viability of huge new oil and gas reserves through horizontal drilling and fracking technologies underscores a simple fact: the U.S. use of fossil fuels cannot be meaningfully reduced by alternative energies within the next two or three decades.”
Acorn Energy attended the Las Vegas Money Show on May 14-17 where CEO, John A. Moore gave a presentation. His presentation, "The Surprising Transformation of Our Energy Structure, Which Will Drive the Next Era of Prosperity" offered his insight into Digital Energy and comment on notable contrasts with both wind and solar energy. Please visit www.acornenergy.com to view additional commentary.
DSIT exhibited the company's underwater security systems and other sonar and acoustic solutions at the Undersea Defence Technologies (UDT) Conference and Exhibition in Alicante, Spain (May 29 – 31, 2012). The company viewed UDT as an important venue for reaching decision makers in fields related to undersea defense and security; and has been an exhibitor at this event for the last several years.
John Moore presented at the Barrington Research Industrial & Business Services Conference on Tuesday, May 15 in Chicago, IL. Acorn Energy presented at the 3rd Annual Benchmark Company, LLC One-on-One Investor Conference Thursday, May 31, 2012 in Milwaukee, WI. The Company attended the SeeThruEquity First Annual Small Cap Investor Conference on Tuesday, June 5, 2012 at The Cornell Club in New York City. The Company is presenting at the 10th Annual Ardour Capital Energy Technology Conference. The conference is in New York City from June 7-8, 2012.
GridSense, an Acorn Energy, Inc. (ACFN) company, previewed Grid InSite™, its new software platform, at the Municipal Smart Grid Summit in San Diego, June 4-6. Grid InSite™ will provide utilities with a powerful grid optimization system that seamlessly integrates GridSense sensors and intelligent nodes to enable monitoring and control of transmission and distribution assets.
Acorn offers a quarterly dividend of $0.035 per share. The dividend helps to make Acorn a very compelling investment opportunity considering the Company has successfully sold two portfolio companies validating its model and is paying a quarterly dividend to shareholders which mitigates some of the risk. The Company’s portfolio consists of 'capital–light' businesses with high or potentially high margins and first mover advantages in what could be billion dollar markets.
For additional information on Acorn Energy, Inc. please download our free update of coverage report dated February 22, 2012; the report is available on our website: www.vistapglobal.com.
TSPT,
Added more shares this time for 6.4 and 6.45 on news that in a 13G filing,Sabby management owns 7.74% of this company
They must have bought in the recent placement at 9 or just in the market at these low prices.
http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=8313064
This is besides the fact that Tang capital owns 9.5% of the company,probably most of it at 9 from the recent privste placement.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=75262148
Manny
TSPT,
Added more shares this time for 6.4 and 6.45 on news that in a 13G filing,Sabby management owns 7.74% of this company
They must have bought in the recent placement at 9 or just in the market at these low prices.
http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=8313064
Manny
ACFN,
Might be a good bottom play.Recent high was 13.20.Currently trading at 8.34 close.It has a quarterly dividend of .035 per share.
Bought some ACFN on news that Verition Funds increased their holding to 8.86% from old holding of 5.2% as of 3/31/12.
http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=8310960
This position was increased from April 1 to may 3,2012.
During this time the stock was a low of 9.64 and a high of 13.20 .
http://finance.yahoo.com/q/hp?s=ACFN+Historical+Prices
Manny
ACFN,
Might be a good bottom play.Recent high was 13.20.Currently trading at 8.34 close.It has a quarterly dividend of .035 per share.
Bought some ACFN on news that Verition Funds increased their holding to 8.86% from old holding of 5.2% as of 3/31/12.
http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=8310960
This position was increased from April 1 to may 3,2012.
During this time the stock was a low of 9.64 and a high of 13.20 .
http://finance.yahoo.com/q/hp?s=ACFN+Historical+Prices
Manny
ACFN,
Might be a good bottom play.Recent high was 13.20.Currently trading at 8.40.
Bought some ACFN on news that Verition Funds increased their holding to 8.86% from old holding of 5.2% as of 3/31/12.
http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=8310960
Manny
ACFN,
Might be a good bottom play.Recent high was 13.20.Currently trading at 8.40.
Bought some ACFN on news that Verition Funds increased their holding to 8.86% from old holding of 5.2% as of 3/31/12.
http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=8310960
Manny
CLSN,
Volume of 852,000,is now more than double the 10 day average volume of 418,729,after less than 2 1/2 hours.
Manny
Celsion Announces Collaboration With the University of Oxford to Design and Execute a Clinical Trial Using Ultrasound-Guided ...
Celsion Corporation (NASDAQ: CLSN), a leading oncology drug development company, today announced a collaboration with the University of Oxford to begin a clinical study of ThermoDox®, Celsion's heat-activated liposomal encapsulation of doxorubicin, in combination with ultrasound-guided High Intensity Focused Ultrasound (HIFU) to treat metastatic liver cancer. The early phase clinical study is being finalized and will require approval from a local Ethics Committee. Treatment of the first patient is targeted for late 2012.
"Both Celsion and Oxford believe there is significant potential of combining ThermoDox® with HIFU to treat cancer," said Michael H. Tardugno, Celsion's President and Chief Executive Officer. "A ThermoDox®/HIFU trial will be an important step in demonstrating that ultrasound-induced hyperthermia can enable the highly targeted delivery of chemotherapeutic agents to tumours non-invasively. ThermoDox® can effectively deliver high concentrations of a proven chemotherapy to a heated tumor. ThermoDox® may be used with multiple heating technologies allowing for us to target an even larger population of patients with cancer."
The trial, which is supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, will be carried out as a multi-disciplinary collaboration between Celsion, the Oxford University Institute of Biomedical Engineering (Prof. Coussios), and the Oxford University Hospitals NHS Trust (Prof. Fergus Gleeson, Radiology, Prof. Mark Middleton, Oncology, and Dr. Tom Leslie, clinical HIFU Unit).
Professor Constantin-C. Coussios, Professor of Biomedical Engineering at the University of Oxford, commented, "This clinical program builds upon many years of experience with clinical ultrasound-guided HIFU, as well as laboratory studies of ThermoDox® release by ultrasound, at our institution. We look forward to exploring the addition of ThermoDox, a well-characterized anti-cancer therapy triggered only by heat, to HIFU, and the potential of this combination to advance treatment within a significantly underserved population."
About ThermoDox®
ThermoDox® is a proprietary heat-activated liposomal encapsulation of doxorubicin, an approved and frequently used oncology drug for the treatment of a wide range of cancers. In the Company's Phase III HEAT Study and Phase II ABLATE Study, ThermoDox® is administered intravenously in combination with Radio Frequency Ablation (RFA). Localized mild hyperthermia (39.5 - 42 degrees Celsius) created by the RFA releases the entrapped doxorubicin from the liposome. This delivery technology enables high concentrations of doxorubicin to be deposited preferentially in a targeted tumor.
The Company's Phase III HEAT Study, a randomized, double-blind, placebo-controlled clinical trial of ThermoDox® in combination with radiofrequency ablation (RFA) for the treatment of hepatocellular carcinoma (HCC), also known as primary liver cancer, is being conducted at 79 clinical sites under an FDA Special Protocol Assessment. The study is designed to evaluate the efficacy of ThermoDox® in combination with RFA when compared to patients who receive RFA alone as the control. The primary endpoint for the study is progression-free survival. The Company's Phase II ABLATE Study is being conducted at four clinical sites in the U.S. and is a randomized, blinded clinical trial of ThermoDox® in combination with RFA for the treatment of colorectal liver metastases with a PFS endpoint. Additional information on the Company's ThermoDox® clinical studies may be found at www.clinicaltrials.gov.
On May 30, 2012, Celsion announced that it had reached its enrollment objective of 700 patients in the HEAT Study. A total of 380 events of progression are required to reach the planned final analysis of the study which is estimated to occur in late 2012. Top line results will be announced following review by the Company's independent Data Monitoring Committee.
About Celsion Corporation
Celsion is a leading oncology company dedicated to the development and commercialization of innovative cancer drugs including tumor-targeting treatments using focused heat energy in combination with heat-activated liposomal drug technology. Celsion has research, license, or commercialization agreements with leading institutions including the National Institutes of Health, Duke University Medical Center, University of Hong Kong, the University of Pisa, the UCLA Department of Medicine, the Kyungpook National University Hospital, the Beijing Cancer Hospital and the University of Oxford.
For more information on Celsion, visit our website: http://www.celsion.com.
Celsion wishes to inform readers that forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Readers are cautioned that such forward-looking statements involve risks and uncertainties including, without limitation, unforeseen changes in the course of research and development activities and in clinical trials by others; possible acquisitions of other technologies, assets or businesses; possible actions by customers, suppliers, competitors, regulatory authorities; and other risks detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission.
Investor Contact
David Pitts
Argot Partners
212-600-1902
Email Contact
CLSN.
Celsion Announces Collaboration With the University of Oxford to Design and Execute a Clinical Trial Using Ultrasound-Guided ...
Celsion Corporation (NASDAQ: CLSN), a leading oncology drug development company, today announced a collaboration with the University of Oxford to begin a clinical study of ThermoDox®, Celsion's heat-activated liposomal encapsulation of doxorubicin, in combination with ultrasound-guided High Intensity Focused Ultrasound (HIFU) to treat metastatic liver cancer. The early phase clinical study is being finalized and will require approval from a local Ethics Committee. Treatment of the first patient is targeted for late 2012.
"Both Celsion and Oxford believe there is significant potential of combining ThermoDox® with HIFU to treat cancer," said Michael H. Tardugno, Celsion's President and Chief Executive Officer. "A ThermoDox®/HIFU trial will be an important step in demonstrating that ultrasound-induced hyperthermia can enable the highly targeted delivery of chemotherapeutic agents to tumours non-invasively. ThermoDox® can effectively deliver high concentrations of a proven chemotherapy to a heated tumor. ThermoDox® may be used with multiple heating technologies allowing for us to target an even larger population of patients with cancer."
The trial, which is supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, will be carried out as a multi-disciplinary collaboration between Celsion, the Oxford University Institute of Biomedical Engineering (Prof. Coussios), and the Oxford University Hospitals NHS Trust (Prof. Fergus Gleeson, Radiology, Prof. Mark Middleton, Oncology, and Dr. Tom Leslie, clinical HIFU Unit).
Professor Constantin-C. Coussios, Professor of Biomedical Engineering at the University of Oxford, commented, "This clinical program builds upon many years of experience with clinical ultrasound-guided HIFU, as well as laboratory studies of ThermoDox® release by ultrasound, at our institution. We look forward to exploring the addition of ThermoDox, a well-characterized anti-cancer therapy triggered only by heat, to HIFU, and the potential of this combination to advance treatment within a significantly underserved population."
About ThermoDox®
ThermoDox® is a proprietary heat-activated liposomal encapsulation of doxorubicin, an approved and frequently used oncology drug for the treatment of a wide range of cancers. In the Company's Phase III HEAT Study and Phase II ABLATE Study, ThermoDox® is administered intravenously in combination with Radio Frequency Ablation (RFA). Localized mild hyperthermia (39.5 - 42 degrees Celsius) created by the RFA releases the entrapped doxorubicin from the liposome. This delivery technology enables high concentrations of doxorubicin to be deposited preferentially in a targeted tumor.
The Company's Phase III HEAT Study, a randomized, double-blind, placebo-controlled clinical trial of ThermoDox® in combination with radiofrequency ablation (RFA) for the treatment of hepatocellular carcinoma (HCC), also known as primary liver cancer, is being conducted at 79 clinical sites under an FDA Special Protocol Assessment. The study is designed to evaluate the efficacy of ThermoDox® in combination with RFA when compared to patients who receive RFA alone as the control. The primary endpoint for the study is progression-free survival. The Company's Phase II ABLATE Study is being conducted at four clinical sites in the U.S. and is a randomized, blinded clinical trial of ThermoDox® in combination with RFA for the treatment of colorectal liver metastases with a PFS endpoint. Additional information on the Company's ThermoDox® clinical studies may be found at www.clinicaltrials.gov.
On May 30, 2012, Celsion announced that it had reached its enrollment objective of 700 patients in the HEAT Study. A total of 380 events of progression are required to reach the planned final analysis of the study which is estimated to occur in late 2012. Top line results will be announced following review by the Company's independent Data Monitoring Committee.
About Celsion Corporation
Celsion is a leading oncology company dedicated to the development and commercialization of innovative cancer drugs including tumor-targeting treatments using focused heat energy in combination with heat-activated liposomal drug technology. Celsion has research, license, or commercialization agreements with leading institutions including the National Institutes of Health, Duke University Medical Center, University of Hong Kong, the University of Pisa, the UCLA Department of Medicine, the Kyungpook National University Hospital, the Beijing Cancer Hospital and the University of Oxford.
For more information on Celsion, visit our website: http://www.celsion.com.
Celsion wishes to inform readers that forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Readers are cautioned that such forward-looking statements involve risks and uncertainties including, without limitation, unforeseen changes in the course of research and development activities and in clinical trials by others; possible acquisitions of other technologies, assets or businesses; possible actions by customers, suppliers, competitors, regulatory authorities; and other risks detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission.
Investor Contact
David Pitts
Argot Partners
212-600-1902
Email Contact
NAVB,
Saw this posted on IV:
Reminder - Webcast of Jefferies presentation today at 4:30 EST
Link: Jefferies 2012 Global Healthcare Conference - NAVB presentation
http://wsw.com/webcast/jeff68/register.aspx?conf=jeff68&page=navb&url=http://wsw.com/webcast/jeff68/navb/
Manny
SARA,
Saratoga Resources, Inc. (NYSE MKT: SARA) (the “Company”) today announced that it will be the recipient of an “Excellence Award” by Oil and Gas Investor magazine. The prestigious awards are presented to seven leading energy firms for outstanding accomplishments and extraordinary efforts in industry leadership, E&P success and financial innovation. The award will be presented at Hart Energy’s 5th Annual Energy Capital Conference on Thursday, June 7, 2012 in Houston, Texas.
Thomas Cooke, Chairman and Chief Executive Officer of Saratoga, stated “It is an honor to be recognized for our accomplishments in 2011. We are particularly proud to be selected by the Oil and Gas Investor magazine and to be included with other industry leading firms such as Apache Corp. (NYSE: APA) (Houston), Energy XXI (Nasdaq: EXXI) (LSE: EXXI) (Houston), SandRidge Energy, Inc. (NYSE: SD) (Oklahoma City) and Kodiak Oil & Gas Corp. (NYSE: KOG) (Denver). This award is particularly sweet coming on the heels of our successful private placement. The company’s strong cash flow and balance sheet positions Saratoga for another great year in 2012.”
About Saratoga Resources
Saratoga is an independent exploration and production Company with offices in Houston, Texas and Covington, Louisiana. Principal holdings cover 32,185 gross/net acres, mostly held-by-production, currently located in the transitional coastline and protected in-bay environment on parish and state leases of south Louisiana. For more information, go to our website at www.saratogaresources.com and sign up for regular updates by clicking on the Updates button.
NAVB,
Navidea Biopharmaceuticals Announces the Presentation of Data at Society of Nuclear Medicine Annual Meeting in June
Date : 06/06/2012 @ 7:00AM
Navidea Biopharmaceuticals, Inc. (NYSE Amex: NAVB), a specialty pharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that data from its Lymphoseek and AZD4694 programs were accepted for presentation at the Society of Nuclear Medicine Annual Meeting from June 9-13 in Miami, Florida. Details of the presentations from the Phase 3 clinical studies investigating Lymphoseek® (Kit for the Preparation of Technetium Tc 99m Tilmanocept for Injection) in head and neck cancer, breast cancer, and melanoma and from Phase 1/Phase 2 clinical trials of its Alzheimer’s Disease candidate, AZD4694 are listed below.
Presentation Title: Receptor targeted (CD206) Tc99m-tilmanocept (TIL) provides for enhanced long-term (>24 hr) stable signal localization in lymph nodes and equally stable concordance with early preoperative imaging in melanoma and breast cancer (M/BC). (No. 278)
Author: Wendy L. Metz, PhD, Navidea Biopharmaceuticals
Session, Date: Molecular Imaging in Breast Cancer I
Tuesday, June 12, 8:00 AM
Presentation Title: Comparison of 11C-PiB and 18F-AZD4694 for Aß imaging in ageing and dementia. (No.149)
Author: Christopher Rowe, et al, Centre for PET, Austin Health,
Melbourne, VIC, Australia
Session, Date: Quantifying Brain Amyloid Signal - Methods & Challenges
Monday, June 11, Room B217/21, 11:00 AM
Poster Title: Correlation of preoperative lymphoscintigraphy with invivo lymphatic mapping in Phase 3 breast cancer & melanoma clinical studies employing a receptor targeted (CD206) ILM agent Tc99m-tilmanocept. (No.1280)
Author: Frederick O. Cope, PhD, Navidea Biopharmaceuticals
Session, Date: MTA I: Breast Cancer Posters
Monday, June 11, Exhibit Hall A-B, 2:30 PM - 4:00 PM
About Navidea Biopharmaceuticals, Inc.
Navidea Biopharmaceuticals, Inc. (NYSE Amex: NAVB) is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents. Navidea is actively developing three radiopharmaceutical agent platforms – Lymphoseek®, AZD4694 and RIGScanTM – to help identify the sites and pathways of undetected disease and enable better diagnostic accuracy, clinical decision-making and ultimately patient care. Navidea’s strategy is to deliver superior growth and shareholder return by bringing to market novel radiopharmaceutical agents and advancing the Company’s pipeline through selective acquisitions, global partnering and commercialization efforts. For more information, please visit www.navidea.com.
NAVB,
Nice to know that the Platinum Funds which owns over 30% of NAVB including options,is a 1.1 BILLION fund.
There was no mention of NAVB yesterday on that Bloomberg interview,but it is good to know that there is so much money available to help NAVB along on its way to the PDUFA date.
Manny
NAVB,
I just saw 51,717 trade at 2.78 after hours,above high of day 2.75.
Manny
NAVB,
I just saw posted that Uri Landesman is going to be on Bloomberg Radio at 4:15 PM.
He is President of Platinum Partners.
Will he be speaking about NAVB on the show?
That would be very interesting.
Manny
NAVB,
Added more shares at 2.69 on this 13 filing by Platinum-Montaur Sciences that it now owns 9.9% of company shares.
This is from a 5.41% holding as of 3/30/12.
http://finance.yahoo.com/q/mh?s=NAVB+Major+Holders
If I remember correctly,with Options, Platinum owns over 30 % of the company.
To me this is saying that Platinum is preparing the maximum percent of shares it can own (9.9%) into the coming PDUFA in September.This tells me they expect the price to go higher into the coming PDUFA date,so they can sell shares into the price rise.
http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=8304016
Manny
NAVB,
Added more shares at 2.69 on this 13D/A filing by Platinum-Montaur Sciences that it now owns 9.9% of company shares.
This is from a 5.41% holding as of 3/30/12.
http://finance.yahoo.com/q/mh?s=NAVB+Major+Holders
If I remember correctly,with Options, Platinum owns over 30 % of the company.
To me this is saying that Platinum is preparing the maximum percent of shares it can own (9.9%) into the coming PDUFA in September.This tells me they expect the price to go higher into the coming PDUFA date,so they can sell shares into the price rise.
http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=8304016
Manny
This site gives you a better total.
55,300 at average 1.471.
http://www.secform4.com/insider-trading/42316.htm
Manny
CLSN,
Up 9.37% to 2.10 on more than 3 times the 10 day average volume of 199,100,after only 1 1/2 hours.
Manny
CLSN,
Up 9.37% to 2.10 on more than 3 times the 10 day average volume of 199,100,after only 1 1/2 hours.
Manny
VHC,
From IV:
ITC Complaint - news update
This guy was just entered under the protective order for VirnetX -
http://www.prnewswire.com/news-releases/itc-trial-lawyer-kent-stevens-joins-mckool-smith-155381985.html
ITC Trial Lawyer Kent Stevens Joins McKool Smith
WASHINGTON, May 29, 2012 /PRNewswire/ -- McKool Smith, one of America's leading trial firms, is announcing that veteran ITC trial lawyer Kent R. Stevens has joined the firm as a Principal in its Washington, DC office. Mr. Stevens has more than 20 years of experience in intellectual property (IP) litigation and specializes in handling Section 337 investigations before the U.S. International Trade Commission (ITC). He also focuses on proceedings relating to ITC investigations before the U.S. Customs and Border Protection and the U.S. Court of Appeals for the Federal Circuit.
"Clients are turning to the ITC for relief against the importation of products that infringe upon their patents," said Mike McKool, co-Founder and Chairman of McKool Smith. "Kent is an expert in ITC litigation and a very well-respected trial lawyer. His expertise will be a valuable asset to our clients and our national IP litigation practice. I am pleased to welcome him to the firm."
"I have always had a great deal of respect for McKool Smith and the firm's track record, particularly in intellectual property litigation," said Mr. Stevens. "When you think of McKool Smith, you associate the firm with first rate trial lawyers and big courtroom verdicts. I am thrilled to have joined such a distinguished group."
Mr. Stevens served as both an Investigative Attorney and Senior Investigative Attorney for the ITC's Office of Unfair Import Investigations. During his ten years of service, he handled cases involving petitions for temporary relief, gray market cases, and numerous patent cases involving pharmaceutical, electronic, and other technologies. He has participated in trials before six ITC Administrative Law Judges and has been in private practice representing complainants, respondents, and third parties since 1998. He also served as a law clerk for the Hon. John J. Mathias in the ITC's Office of Administrative Law Judges. Mr. Stevens is a former President of the ITC Trial Lawyers Association and a frequent speaker on international trade issues relating to intellectual property litigation. He is listed in the US Legal 500 and Intellectual Asset Management (IAM) Magazine's "IAM 250" listing of leading intellectual property strategists.
Mr. Stevens earned his B.A., M.P.A., and J.D. from Drake University and an LL.M. in International and Comparative Law from the Georgetown University Law Center.
McKool Smith recently announced the opening of an office in Silicon Valley, marking the firm's eighth office and second in California. In September 2011, the members of Hennigan Dorman, a Los Angeles-based trial firm, joined McKool Smith. This added 35 trial lawyers to McKool Smith's roster and expanded the firm's intellectual property litigation and commercial litigation practices to the West Coast.
With more than 170 litigators across offices in Austin, Dallas, Houston, Los Angeles, Marshall, New York, Silicon Valley, and Washington, DC, McKool Smith has established a reputation as one of America's leading trial firms. The firm has won more National Law Journal and VerdictSearch "Top 100 Verdicts" over the last five years than any other law firm. In 2012, the firm was named intellectual property "Firm of the Year" by Benchmark Litigation, and previously was recognized as "IP Firm of the Year" by Law360. McKool Smith represents leading clients across a broad range of practice areas, including complex commercial litigation, intellectual property, bankruptcy, and white collar defense.
For more information, please contact Diane Iselin at 212-402-9486 or diselin@mckoolsmith.com.
SOURCE McKool Smith
Back to top
RELATED LINKS
http://www.mckoolsmith.com
Source: PR Newswire (http://s.tt/1cVMf)